Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 Forbidden error in place of the study record details, with a basic header/footer visible, indicating access restrictions to the resource.SummaryDifference17%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous revision v3.6.5, indicating a deployment update.SummaryDifference0.1%

- Check30 days agoChange DetectedA new entry under the study identifiers notes a 2019 U.S. NIH grant/contract. This addition records the funding source associated with the study as part of its identifiers.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a backend/software update. The change does not alter the study details or page content.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision indicator updated to v3.6.4, signaling a software update. No study details or layout changes are evident.SummaryDifference0.1%

- Check81 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the study record metadata.SummaryDifference0.1%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.